Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Novo Nordisk's oral diabetes drug cuts heart-related risks by 14% in study
Novo Nordisk said on Monday an oral version of its drug semaglutide, helped significantly reduce the risk of cardiovascular ...
healthday7m
Ozempic Curbs Kidney Disease in Obese People Without Diabetes
The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows.Patients taking semag ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News
Eli Lilly expects to start selling its weight-loss drug in Hong Kong as early as the end of this year, Bloomberg News ...
devdiscourse4h
Major Developments in Health Industry: New Drug Approval, E. coli Safety, and Corporate Controversies
This report summarizes recent health news, covering Eli Lilly's Hong Kong approval for its weight-loss drug, a McDonald's E.
UPI10d
Study: Men using diabetes drug metformin won't increase birth defect risk
A new, reassuring study finds that men can take the diabetes drug metformin without worrying that their offspring will ...
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
GLP-1 drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...